as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
8.96%
Downside
2.99%
Upside
52 Week's Low
52 Week's High
80.75%
Downside
92.54%
Upside
Check Rani Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$278.4M
EPS (TTM)
-0.49
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-44.5M
Revenue (TTM)
1.2M
Profit Margin
0.00%
Return On Equity TTM
-1187.52%
Compare market cap, revenue, PE, and other key metrics of Rani Therapeutics Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $278.4M | NA | NA | 0.00% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
The Rani Therapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rani Therapeutics Holdings Inc investment value today
Current value as on today
₹88,550
Returns
Returns from Rani Therapeutics Holdings Inc Stock
Dollar Returns*
₹5,147 (+5.15%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Rani Therapeutics Holdings Inc. Average target price of $9.5
Get share price movements and forecasts by analysts on Rani Therapeutics Holdings Inc.
What analysts predicted
78.84%UPSIDE
Target Price
$9.5
Current Price
$2.01
Analyzed by
13 Analysts
Target
$9.50
Rani Therapeutics Holdings Inc target price $9.5, a slight upside of 78.84% compared to current price of $2.01. According to 13 analysts rating.
Investment in Rani Therapeutics Holdings Inc Shares on INDmoney has grown by 19785.71% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:19785.71% versus previous 30 day period
Search interest for Rani Therapeutics Holdings Inc Stock has increased by 8722% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:8722% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, RANI stock has moved up by 363.2%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 158.3%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 962.3%
| Organisation | Rani Therapeutics Holdings Inc |
| Headquarters | 2051 Ringwood Avenue, San Jose, CA, United States, 95131 |
| CEO | Mr. Talat Imran |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Arvinder Dhalla | Vice President of Clinical Development |
Mr. Talat Imran | CEO & Director |
Mr. Svai S. Sanford | Chief Financial Officer |
Dr. Mir Hashim | Chief Scientific Officer |
Mr. Alireza Javadi | Vice President of Technical Operations |
Ms. Bella Vazquez | Vice President of Human Resources |
Ms. Kate McKinley M.B.A. | Chief Business Officer |
Mr. Mir A. Imran | Executive Chairman |
Ms. Betsy Gutierrez | Senior Vice President of Quality Assurance |
Rani Therapeutics Holdings Inc share price today is $2.01 as on at the close of the market. Rani Therapeutics Holdings Inc share today touched a day high of $2.07 and a low of $1.83.
Rani Therapeutics Holdings Inc share touched a 52 week high of $3.87 on and a 52 week low of $0.39 on . Rani Therapeutics Holdings Inc stock price today i.e. is closed at $2.01,which is 48.06% down from its 52 week high and 419.38% up from its 52 week low.
Rani Therapeutics Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Rani Therapeutics Holdings Inc (RANI) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Rani Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rani Therapeutics Holdings Inc share’s latest price of $2.01 as on November 8, 2025 at 2:29 am IST, you will get 4.9751 shares of Rani Therapeutics Holdings Inc. Learn more about
fractional shares .